Novartis India Ltd.

Name: Novartis India Ltd. Share Price Today, Stock Analysis
Brand: Novartis India Ltd.

Stock Card

NSE: NOVARTIND | BSE: 500672

₹1,952.70

₹28.60 (1.49%)

As on 30-Sep-2026 11:24IST

Market cap

₹4,847 Cr

Revenue (TTM)

₹371 Cr

P/E Ratio

49.6

P/B Ratio

5.7

Div. Yield

0 %

Value Research Rating

Quality Score

8/10

Growth Score

6/10

Valuation Score

3/10

Momentum Score

10/10

Know more

Explore 5 star rated stocks

Novartis India Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1,924.10 High: 2,030.70

52 Week Range

Low: 950.00 High: 2,588.80

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹98 Cr
ROE

11.6 %
ROCE

16.3 %
Industry P/E

47.49
EV/EBITDA

30.1
Debt to Equity

0
Book Value

₹344.3
EPS

₹39.6
Face value

5
Shares outstanding

24,690,797

10 Years Aggregate

CFO

₹151.70 Cr

EBITDA

₹408.47 Cr

Net Profit

₹597.24 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Novartis India	--	31.4	35.6	--	39.4	19.0	--
BSE Healthcare	15.4	-2.9	2.2	16.3	20.7	14.0	12.0

As on 30-Sep-2026

Company	2022	2021
Novartis India	-13.1	12.5
BSE Small Cap	-1.8	62.8
BSE Healthcare	-12.1	20.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Novartis India	1,952.7	4,846.8	370.6	97.8	27.0	12.3	49.6	5.7
Acutaas Chemicals	3,277.2	27,126.0	1,461.8	387.4	34.5	25.2	70.2	15.7
Alembic Pharma	847.2	17,225.8	7,784.0	688.5	10.6	14	24.8	2.9
Cohance Lifesciences	449.5	17,555.5	2,141.5	58.5	5.8	3.3	165.3	4.6
Granules India	855.8	23,765.9	5,632.3	662.4	17.2	14.3	35.9	4.8
Jubilant Pharmova	1,039.0	16,816.1	8,608.3	351.6	8.7	5.7	47.8	2.4
Onesource Specialty Pharma	1,552.5	18,339.8	1,543.3	-48.6	3.6	-0.6	--	3.1
Piramal Pharma	205.8	27,885.1	9,205.3	-371.8	1.7	-3.8	--	3.5
Rubicon Research	1,600.7	26,586.9	1,935.8	288.2	20.6	29.8	92.2	19.8
Wockhardt	2,155.5	35,943.3	3,564.0	414.0	15.3	8.4	87.9	7.1

Shareholding Pattern

View Details

News & Analysis

All News

Dubious discounts

3 min read•By Ashish Jain

About Novartis India

Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and... Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG. Read more

Incorporated

1947
Chairman

Ramesh Ramadurai
Managing Director

Vikas Gupta
Group

Novartis India - MNC
Headquarters

Mumbai, Maharashtra
Website

www.nilpharma.co.in

Looking for more details about Novartis India Ltd.’s IPO? Explore our IPO Details page.

FAQs for Novartis India

What is the current share price of Novartis India Ltd Today?

The share price of Novartis India Ltd is ₹1,952.70 (NSE) and ₹1,949.70 (BSE) as of 30-Sep-2026 11:24 IST. Novartis India Ltd has given a return of 39.43% in the last 3 years.

What is the current PB & PE ratio of Novartis India Ltd?

The P/E ratio of Novartis India Ltd is 49.57 times as on 30-Sep-2026, a 4 premium to its peers’ median range of 47.49 times.
The P/B ratio of Novartis India Ltd is 5.70 times as on 30-Sep-2026, a 18 premium to its peers’ median range of 4.83 times.

PE & PB ratio at the end of financial year.